Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


04.12.2017

1 Am J Case Rep
1 Am J Hematol
2 Cardiol J
1 Cell Physiol Biochem
2 Circulation
1 Echocardiography
1 Eur J Heart Fail
1 Exp Lung Res
5 Int J Cardiol
2 J Am Soc Echocardiogr
1 J Bras Pneumol
1 J Cardiothorac Vasc Anesth
1 J Cardiovasc Pharmacol
1 J Med Life
2 J Pediatr Surg
1 J Perinatol
1 J Pharmacol Exp Ther
1 Lancet Respir Med
1 Nat Rev Mol Cell Biol
1 Neonatology
1 Pediatr Int
1 Pediatr Res
1 PLoS One
1 Redox Biol
4 Respir Med
1 Respir Res
1 Rev Med Inst Mex Seguro Soc
1 Sci Rep
1 Ter Arkh
2 Ther Adv Respir Dis
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Case Rep

  1. SARSAM S, Kaspar G, David S, Zughaib M, et al
    Early Detection of Subclinical Aortic Valve Endocarditis with the CardioMEMS Heart Failure System.
    Am J Case Rep. 2017;18:665-668.
    PubMed     Text format     Abstract available


    Am J Hematol

  2. JACOB SA, Novelli EM, Isenberg JS, Garrett ME, et al
    Thrombospondin-1 Gene Polymorphism is Associated with Estimated Pulmonary Artery Pressure in Patients with Sickle Cell Anemia.
    Am J Hematol. 2016 Dec 29. doi: 10.1002/ajh.24635.
    PubMed     Text format    


    Cardiol J

  3. MALACZYNSKA-RAJPOLD K
    Response to the comment on the article entitled "Balloon atrial septostomy in pulmonary arterial hypertension: A beneficial effect on the control of rhythm abnormalities".
    Cardiol J. 2017;24:457.
    PubMed     Text format    

  4. SABINIEWICZ R
    Baloon atrial septostomy in pulmonary arterial hypertension: Atrial flow regulator - New therapeutic option.
    Cardiol J. 2017;24:455-456.
    PubMed     Text format    


    Cell Physiol Biochem

  5. SUN Z, Nie X, Sun S, Dong S, et al
    Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway.
    Cell Physiol Biochem. 2017;42:2569-2581.
    PubMed     Text format     Abstract available


    Circulation

  6. SAITO T, Miyagawa K, Chen SY, Tamosiuniene R, et al
    Upregulation of HERV-K is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 21. pii: CIRCULATIONAHA.117.027589.
    PubMed     Text format     Abstract available

  7. HADINNAPOLA C, Bleda M, Haimel M, Screaton N, et al
    Phenotypic Characterisation of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.028351.
    PubMed     Text format     Abstract available


    Echocardiography

  8. MENG X, Li Y, Li H, Lv X, et al
    Three-dimensional echocardiography to evaluate right atrial volume and phasic function in pulmonary hypertension.
    Echocardiography. 2017 Nov 26. doi: 10.1111/echo.13761.
    PubMed     Text format     Abstract available


    Eur J Heart Fail

  9. FARMAKIS D, Triposkiadis F, Lekakis J, Parissis J, et al
    Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management.
    Eur J Heart Fail. 2016 Dec 20. doi: 10.1002.
    PubMed     Text format     Abstract available


    Exp Lung Res

  10. XU Y, Gu Q, Qu C
    Capsaicin pretreatment reversed pulmonary arterial hypertension by alleviating inflammation via p38MAPK pathway.
    Exp Lung Res. 2017;43:8-18.
    PubMed     Text format     Abstract available


    Int J Cardiol

  11. DI MAURO M, Foschi M, Tancredi F, Guarracini S, et al
    Additive and independent prognostic role of abnormal right ventricle and pulmonary hypertension in mitral-tricuspid surgery.
    Int J Cardiol. 2017 Nov 14. pii: S0167-5273(17)34990.
    PubMed     Text format    

  12. GONZALEZ-SAIZ L, Fiuza-Luces C, Sanchis-Gomar F, Santos-Lozano A, et al
    Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: The WHOLEi+12 trial.
    Int J Cardiol. 2017;231:277-283.
    PubMed     Text format     Abstract available

  13. DUO-JI MM, Long ZW
    Comparative efficacy and acceptability of endothelin receptor antagonists for pulmonary arterial hypertension: A network meta-analysis.
    Int J Cardiol. 2017;234:90-98.
    PubMed     Text format     Abstract available

  14. GALIE N, Denton CP, Dardi F, Manes A, et al
    Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease.
    Int J Cardiol. 2017;235:67-72.
    PubMed     Text format     Abstract available

  15. GHIO S, D'Alto M, Badagliacca R, Vitulo P, et al
    Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension.
    Int J Cardiol. 2017;230:53-58.
    PubMed     Text format     Abstract available


    J Am Soc Echocardiogr

  16. BAR N, Schwartz LA, Biner S, Aviram G, et al
    Clinical Outcome of Isolated Tricuspid Regurgitation in Patients with Preserved Left Ventricular Ejection Fraction and Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2017 Nov 28. pii: S0894-7317(17)30687.
    PubMed     Text format     Abstract available

  17. HELLENKAMP K, Unsold B, Mushemi-Blake S, Shah AM, et al
    Echocardiographic Estimation of Mean Pulmonary Artery Pressure: A Comparison of Different Approaches to Assign the Likelihood of Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2017 Nov 23. pii: S0894-7317(17)30686.
    PubMed     Text format     Abstract available


    J Bras Pneumol

  18. FERREIRA JC, Patino CM
    Types of outcomes in clinical research.
    J Bras Pneumol. 2017;43:5.
    PubMed     Text format    


    J Cardiothorac Vasc Anesth

  19. RAMADAN ME, Shabsigh M, Awad H
    Con: Inhaled Pulmonary Vasodilators Are Not Indicated in Patients Undergoing Lung Transplantation.
    J Cardiothorac Vasc Anesth. 2016 Aug 31. pii: S1053-0770(16)30374.
    PubMed     Text format    


    J Cardiovasc Pharmacol

  20. CAMPOS C, Luz de Castro A, Vicente Tavares AM, Fernandes RO, et al
    Effect of free and nanoencapsulated copaiba oil on monocrotaline-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    J Med Life

  21. NEGOI RI, Ghiorghiu I, Filipoiu F, Hostiuc M, et al
    Severe pulmonary arterial hypertension associated with congenital cardiac shunts: evolution under specific treatment.
    J Med Life. 2017;10:131-138.
    PubMed     Text format     Abstract available


    J Pediatr Surg

  22. WILD B, St-Pierre ME, Langlois S, Cowan KN, et al
    Elastase and matrix metalloproteinase activities are associated with pulmonary vascular disease in the nitrofen rat model of congenital diaphragmatic hernia.
    J Pediatr Surg. 2017 Jan 27. pii: S0022-3468(17)30042.
    PubMed     Text format     Abstract available

  23. ZIMMER J, Takahashi T, Hofmann AD, Puri P, et al
    Downregulation of KCNQ5 expression in the rat pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia.
    J Pediatr Surg. 2017 Jan 26. pii: S0022-3468(17)30048.
    PubMed     Text format     Abstract available


    J Perinatol

  24. SURESH G, King BC, Jain SK
    Screening for pulmonary hypertension in preterm infants-not ready for prime time.
    J Perinatol. 2017 Nov 27. pii: 10.1038/s41372-017-0014.
    PubMed     Text format    


    J Pharmacol Exp Ther

  25. CORBOZ MR, Li Z, Malinin V, Plaunt AJ, et al
    Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug.
    J Pharmacol Exp Ther. 2017;363:348-357.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  26. HOEPER MM, McLaughlin VV, Barbera JA, Frost AE, et al
    Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.
    Lancet Respir Med. 2016;4:894-901.
    PubMed     Text format     Abstract available


    Nat Rev Mol Cell Biol

  27. PANCIERA T, Azzolin L, Cordenonsi M, Piccolo S, et al
    Mechanobiology of YAP and TAZ in physiology and disease.
    Nat Rev Mol Cell Biol. 2017;18:758-770.
    PubMed     Text format     Abstract available


    Neonatology

  28. YOUNG KC, Bancalari E
    Should All Extremely Premature Infants Be Screened for Pulmonary Hypertension?
    Neonatology. 2017;113:89-91.
    PubMed     Text format    


    Pediatr Int

  29. KARPUZ D, Giray D, Celik Y, Hallioglu O, et al
    Prognostic Markers in Congenital Diaphragmatic Hernia: Left Ventricular Diameter and Pulmonary Hypertension.
    Pediatr Int. 2017 Nov 27. doi: 10.1111/ped.13464.
    PubMed     Text format     Abstract available


    Pediatr Res

  30. BURGOS CM, Pearson EG, Davey M, Riley J, et al
    Improved pulmonary function in the nitrofen model of congenital diaphragmatic hernia following prenatal maternal dexamethasone and/or sildenafil.
    Pediatr Res. 2016 Jul 4. doi: 10.1038/pr.2016.
    PubMed     Text format     Abstract available


    PLoS One

  31. GHIO S, Crimi G, Pica S, Temporelli PL, et al
    Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.
    PLoS One. 2017;12:e0188383.
    PubMed     Text format     Abstract available


    Redox Biol

  32. XU T, Liu S, Ma T, Jia Z, et al
    Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension.
    Redox Biol. 2017;11:286-296.
    PubMed     Text format     Abstract available


    Respir Med

  33. SHAPIRO S, Torres F, Feldman J, Keogh A, et al
    Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1).
    Respir Med. 2017;126:84-92.
    PubMed     Text format     Abstract available

  34. DISTLER O, Pope J, Denton C, Allanore Y, et al
    RISE-SSc: Riociguat in diffuse cutaneous systemic sclerosis.
    Respir Med. 2017;122 Suppl 1:S14-S17.
    PubMed     Text format     Abstract available

  35. MATHAI SC, Minai O, Sullivan SD, Lerner D, et al
    Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment.
    Respir Med. 2017;122 Suppl 1:S23-S27.
    PubMed     Text format     Abstract available

  36. HOEPER MM, Klinger JR, Benza RL, Simonneau G, et al
    Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors.
    Respir Med. 2017;122 Suppl 1:S18-S22.
    PubMed     Text format     Abstract available


    Respir Res

  37. COSTE F, Guibert C, Magat J, Abell E, et al
    Chronic hypoxia aggravates monocrotaline-induced pulmonary arterial hypertension: a rodent relevant model to the human severe form of the disease.
    Respir Res. 2017;18:47.
    PubMed     Text format     Abstract available


    Rev Med Inst Mex Seguro Soc

  38. SANTOS-MARTINEZ LE, Orihuela-Rodriguez O, Rodriguez-Almendros NA, Carmona-Ruiz H, et al
    [The pulmonary hypertension of the chronic kidney disease].
    Rev Med Inst Mex Seguro Soc. 2017;55:621-631.
    PubMed     Text format     Abstract available


    Sci Rep

  39. WALLNER M, Eaton DM, Berretta RM, Borghetti G, et al
    A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function.
    Sci Rep. 2017;7:16587.
    PubMed     Text format     Abstract available


    Ter Arkh

  40. PONOMAREV RV, Model SV, Averbukh OM, Gavrilov AM, et al
    [Progressive pulmonary hypertension in a patient with type 1 Gaucher disease].
    Ter Arkh. 2017;89:71-74.
    PubMed     Text format     Abstract available


    Ther Adv Respir Dis

  41. HAHN SS, Makaryus M, Talwar A, Narasimhan M, et al
    A review of therapeutic agents for the management of pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2017;11:46-63.
    PubMed     Text format     Abstract available

  42. GRIFFIN M, Trow TK
    The evolving landscape of combination therapy for pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2017;11:91-95.
    PubMed     Text format     Abstract available


    Thorax

  43. PRICE LC, Dimopoulos K, Marino P, Alonso-Gonzalez R, et al
    The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension.
    Thorax. 2017;72:1035-1045.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: